Trial Profile
Observational Study of Low Dose FCR in the Treatment of Elderly/Comorbid Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: The Q-lite Project
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Cyclophosphamide (Primary) ; Fludarabine (Primary) ; Fludarabine (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Acronyms Q-lite; The Q-lite Project
- 21 Jun 2020 Status changed from active, no longer recruiting to completed.
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association
- 04 Jul 2014 New trial record